McKesson Corporation (MCK)

Return on equity (ROE)

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Net income (ttm) US$ in thousands 3,295,000 2,826,000 2,536,000 2,959,000 3,002,000 2,998,000 3,488,000 3,750,000 3,560,000 3,141,000 2,055,000 1,396,000 1,114,000 1,412,000 -4,807,000 -4,497,000 -4,539,000 -4,184,000 2,228,000 921,000
Total stockholders’ equity US$ in thousands -2,074,000 -3,084,000 -3,017,000 -1,755,000 -1,971,000 -2,053,000 -1,828,000 -1,602,000 -1,857,000 -2,455,000 -1,767,000 -2,004,000 -2,272,000 -1,274,000 -571,000 -529,000 -21,000 -477,000 5,890,000 5,446,000
ROE — — — — — — — — — — — — — — — — — — 37.83% 16.91%

March 31, 2025 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $3,295,000K ÷ $-2,074,000K
= —

McKesson Corporation's return on equity (ROE) has shown variability over the periods reported. As of September 30, 2020, the ROE was 37.83%, indicating a strong performance in generating profit relative to shareholder equity. This improved ROE suggests efficient use of equity to generate earnings.

However, the absence of reported ROE figures from December 2020 to March 2025 indicates a lack of available data for ROE analysis during these periods. It is crucial to monitor and analyze company performance consistently to gain insights into its financial health and efficiency in utilizing shareholders' equity.

In conclusion, McKesson Corporation demonstrated a robust ROE as of September 30, 2020, but the lack of subsequent data limits a comprehensive analysis of their return on equity trend and performance over time.

Peer comparison

Mar 31, 2025

Company name
Symbol
ROE
McKesson Corporation
MCK
—
Cardinal Health Inc
CAH
—
Cencora Inc.
COR
233.63%

See also:

McKesson Corporation Return on Equity (ROE) (Quarterly Data)